Early screening for ovarian cancer

Ovarian cancer is one of the common malignant tumor in female reproductive system,early detection of ovarian cancer can significantly improve the prognosis,and effective early screening is the key to achieve this goal.With the progress of the study,human epididymis secretory protein 4(HE4)was known as a new serum tumor marker.The measurement of HE4 combined CA125 has a good clinical value in early diagnosis of ovarian cancer,can discriminate ovarian endometriosis cysts from ovarian cancer and predict high risk of ovarian cancer from pelvic mass women effectively.And then it is expected to make contributions to effective early screening.